Zenlabs Ethica Ltd.

BSE: 530697 SECTOR: Finance - Investment  1238   1   0

33.90
+0.55 (1.65%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 34

Today's Low

₹ 31.05

52 Week High

₹ 54.8

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

22.07 Cr.

Advances

0 Cr.

No. of Shares

0.65 Cr.

P/E

20.27

P/B

2.46

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  13.77

Operating Revenue

56.64 Cr.

Net Profit

0.92 Cr.

Promoter Holding

67.61 %

EPS (TTM)

₹  1.67

Sales Growth

-10.92

ROE

-11.05 %

ROCE

-11.27%

Profit Growth

-168.58 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year-5.52%
3 Year-7.62%
5 Year29.17%

Profit Growth

1 Year206.21%
3 Year-7.53%
5 Year40.14%

ROE%

1 Year11.63%
3 Year5.7%
5 Year10.65%

ROCE %

1 Year14.68%
3 Year8.95%
5 Year14.35%

ROA%

2.81373851742948

PEG Ratio

NA

PAT Margin (%)

-1.44533570496701

EPS Growth(%)

NA

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 67.61 0
Jun 2021 67.61 0
Mar 2021 67.61 0
Dec 2020 67.6 0
Sep 2020 67.6 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Promoters shareholding is 67.61%.

 Limitations

  • The company has delivered poor profit growth of -9.60388754741654% over past 3 years
  • The company has delivered poor Operating Income growth of -7.61753388639865% over past 3 years.
  • Provision and contingencies have increased by 218.07182306304%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
Operating Revenue 15.04 14.85 13.79 18.9 18.33
Other Income 0.02 0.02 0.04 0.02 0.04
Interest Expended 0.01 0.01 0.01 0.01 0.02
Operating Expenses 14.77 14.56 13.35 18.46 17.89
Total Provisions 0 0 0 0 0
Depreciation 0.08 0.1 0.04 0.06 0.06
Profit Before Tax 0.2 0.2 0.43 0.4 0.4
Tax 0 0 0.09 0.1 0.15
Net Profit 0.2 0.2 0.34 0.3 0.25

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Operating Income 81.16 71.84 67.3 59.95 56.64
Other Income 0.08 0.1 0.16 0.07 0.12
Interest 0.1 0.09 0.07 0.23 0.29
Operating Expenses 79.87 69.96 65.42 60.51 55.09
Total Provisions 0.04 0.23 0.07 0.44 0.46
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.23 1.65 1.89 -1.17 0.92
Tax 0.28 0.49 0.63 -0.3 0
Profit After Tax 0.95 1.16 1.26 -0.87 0.92
Adjusted EPS (Rs.) 1.46 1.79 1.94 -1.33 1.41

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 6.2 6.2 6.51 6.51 6.51
Total Reserves -0.41 0.81 1.77 0.9 1.91
Borrowings 0.58 0.35 0.28 0.32 0.23
Other N/C liabilities 0.12 0.1 0.26 0.02 -0.06
Current liabilities 26.84 22.28 26.07 25.89 23.17
Total Liabilities 33.33 29.75 34.89 33.65 31.77
Assets
Loans 0 0 0 0 0
Net Block 1.5 1.33 1.36 1.12 1.39
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.95 0.7 0.7 0.7 0.7
Other Loans 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 30.88 27.71 32.83 31.83 29.68
Total Assets 33.33 29.75 34.89 33.65 31.77
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 67.60 67.60 67.61 67.61 67.61
preet remedies pvt... 30.78 30.78 - - -
preet remedies lim... - - 30.78 30.78 30.78
sanjay dhir 10.42 10.42 10.42 10.42 13.18
sanjeev kumar sing... - - 10.42 10.42 13.17
harpreet singh kal... 10.41 10.41 10.41 10.41 10.41
sanjeev kumar sing... 10.42 10.42 - - -
satish kumar 5.51 5.51 5.51 5.51 -
daman singhal 0.02 0.02 0.02 0.02 0.02
harjinder kaur 0.02 0.02 0.02 0.02 0.02
himjyoti 0.02 0.02 0.02 0.02 0.02
jasbir singh 0.02 0.02 0.02 0.02 0.02
jasbir singh kalra - - - - -
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 32.40 32.40 32.39 32.39 32.39
arvind ramgopal bo... 1.80 1.54 1.47 1.03 -
multibagger securi... 2.02 2.02 - - -
multibagger securi... - - - 2.01 1.54
multibagger securi... - - 1.62 - -
sangeeta a bohra 1.26 - 1.11 - -
sangeeta a bohra . - 1.09 - - -
manish kumar goyal - - - - -
dinesh lohia 1.26 1.24 1.19 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Zenlabs Ethica Stock Price Analysis and Quick Research Report. Is Zenlabs Ethica an attractive stock to invest in?

 

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

To understand the functions of the Zenlabs Ethica better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of the company is Rs -0.8664708 Cr and the compounded growth of profit in the past 3 years is -196.922909142295 %. The PAT margin of Zenlabs Ethica is -1.44533570496701 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Zenlabs Ethica , the EPS #if( -168.579967023908 > 0) then "grew" else "declined";# by -168.579967023908 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): The Company has a #if( -11.0461682607394 >= 20) then "healthy" elseif( -11.0461682607394 < 20 and -11.0461682607394 >=10) then "average" else "poor";# ROE track record. The ROE of Zenlabs Ethica is at -11.0461682607394 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Zenlabs Ethica is worth at the current levels at Rs $$PRICE_Y_1$$. The stock is trading at a current P/E ratio of 0 and the average historical P/E for the last 5 years was 27.1047186419569.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Zenlabs Ethica is trading at a P/B of 2.401 . The average historical P/B for the last 5 years was 3.62585949839709. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

Brief about Zenlabs Ethica

X